Contact
searchSearch
HMP Global

Venous Disease

Features

Fortegra
Sponsored Video
GORE® VIABAHN® FORTEGRA Venous Stent
11/01/2026
Purpose-built for the treatment of IVC obstruction—with or without combined iliofemoral obstruction—the FORTEGRA Venous Stent is the first deep venous stent indicated specifically for this anatomy.
Purpose-built for the treatment of IVC obstruction—with or without combined iliofemoral obstruction—the FORTEGRA Venous Stent is the first deep venous stent indicated specifically for this anatomy.
Purpose-built for the treatment...
11/01/2026
Vascular Disease Management
Zola N'Dandu, MD
AMP 2026
Unmet Needs in Deep Venous Arterialization Technology
10/07/2026
Zola N'Dandu, MD
Zola N'Dandu, MD, discusses one of the presentations he gave at the 2026 Amputation Prevention Symposium on what is needed to successfully perform deep venous arterialization.
Zola N'Dandu, MD, discusses one of the presentations he gave at the 2026 Amputation Prevention Symposium on what is needed to successfully perform deep venous arterialization.
Zola N'Dandu, MD, discusses one...
10/07/2026
Vascular Disease Management
Fadi Saab MD
AMP 2026
Lessons Learned Throughout the Deep Venous Arterialization Evolution: Yesterday and Today
09/29/2026
Fadi Saab, MD, FACC, FSCAI
In this video, interventional cardiologist Fadi Saab, MD discusses one of the presentations he gave at AMP 2026.
In this video, interventional cardiologist Fadi Saab, MD discusses one of the presentations he gave at AMP 2026.
In this video, interventional...
09/29/2026
Vascular Disease Management
Jill Sommerset RVT
AMP 2026
Pre-op Mapping for Deep Vein Arterialization
09/28/2026
Jill Sommerset, RVT
Jill Sommerset, RVT, FSVU, discusses her AMP 2026 presentation on pre-op mapping for DVA.
Jill Sommerset, RVT, FSVU, discusses her AMP 2026 presentation on pre-op mapping for DVA.
Jill Sommerset, RVT, FSVU,...
09/28/2026
Vascular Disease Management
Dr Yana Etkin
AMP 2026
Failing Deep Vein Arterialization: Early Detection and Timely Reintervention Strategies
09/22/2026
Yana Etkin, MD, FSVS, FACS
Vascular surgeon Yana Etkin, MD, discusses her AMP 2026 presentation on failing deep vein arterialization. 
Vascular surgeon Yana Etkin, MD, discusses her AMP 2026 presentation on failing deep vein arterialization. 
Vascular surgeon Yana Etkin, MD,...
09/22/2026
Vascular Disease Management
Mike Watts, MD, FSIR
AMP 2026
When Economics Meets Innovation: Matching Deep Venous Arterialization to the Right Site of Service
08/07/2026
Mike Watts, MD, FSIR
Dr Mike Watts examines an important question surrounding DVA: not simply whether the procedure can prevent amputation in patients with no-option CLTI, but how the economics of care delivery influence where and how it can be successfully...
Dr Mike Watts examines an important question surrounding DVA: not simply whether the procedure can prevent amputation in patients with no-option CLTI, but how the economics of care delivery influence where and how it can be successfully...
Dr Mike Watts examines an...
08/07/2026
Vascular Disease Management
Dr Yana Etkin
AMP 2026
Early Detection and Timely Reintervention Drive Success After Deep Venous Arterialization
08/07/2026
Yana Etkin, MD, FSVS, FACS
Yana Etkin, MD,  presented an in-depth review of strategies for identifying and managing failing DVA, emphasizing that long-term success depends not only on creating the DVA circuit but also on maintaining its patency through vigilant...
Yana Etkin, MD,  presented an in-depth review of strategies for identifying and managing failing DVA, emphasizing that long-term success depends not only on creating the DVA circuit but also on maintaining its patency through vigilant...
Yana Etkin, MD,  presented an...
08/07/2026
Vascular Disease Management
Chronic Venous Disease
InVera Medical Reports 12-Month Results From Pilot Trial of InVera Infusion Device Showing Vein Closure in 90% of Patients, Statistically Significant Quality of Life Improvements, and Excellent Safety
04/21/2026
Novel Non-Thermal Procedure for Chronic Venous Disease Designed to Effectively Eliminate Need for Painful Injections Required for Thermal Ablation
Novel Non-Thermal Procedure for Chronic Venous Disease Designed to Effectively Eliminate Need for Painful Injections Required for Thermal Ablation
Novel Non-Thermal Procedure for...
04/21/2026
Vascular Disease Management
Post-Thrombotic Syndrome
Pivotal Study of Minimally Invasive Stent Therapy Shows Improved Quality of Life for Patients With Blood Clots
04/12/2026
NIH-sponsored C-TRACT Trial finds opportunity to treat often ignored DVT complication. TORONTO (April 13, 2026)—The results of a prominent, National Institutes of Health (NIH) sponsored study into the treatment of post-thrombotic syndrome...
NIH-sponsored C-TRACT Trial finds opportunity to treat often ignored DVT complication. TORONTO (April 13, 2026)—The results of a prominent, National Institutes of Health (NIH) sponsored study into the treatment of post-thrombotic syndrome...
NIH-sponsored C-TRACT Trial...
04/12/2026
Vascular Disease Management
Dr Salazar speaks at ISET 2026
ISET 2026
Venous Valve Technology: When Will It Be Standard of Care?
04/01/2026
Gloria Salazar, MD, FSIR
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current...
04/01/2026
Vascular Disease Management
Dr Mike Watts
ISET 2026
How I Do It: Distal Deep Venous Arterialization in the OBL
02/11/2026
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from...
02/11/2026
Vascular Disease Management

Videos & Podcasts

Fortegra
Sponsored Video
GORE® VIABAHN® FORTEGRA Venous Stent
11/01/2026
Purpose-built for the treatment of IVC obstruction—with or without combined iliofemoral obstruction—the FORTEGRA Venous Stent is the first deep venous stent indicated specifically for this anatomy.
Purpose-built for the treatment of IVC obstruction—with or without combined iliofemoral obstruction—the FORTEGRA Venous Stent is the first deep venous stent indicated specifically for this anatomy.
Purpose-built for the treatment...
11/01/2026
Vascular Disease Management
Zola N'Dandu, MD
AMP 2026
Unmet Needs in Deep Venous Arterialization Technology
10/07/2026
Zola N'Dandu, MD
Zola N'Dandu, MD, discusses one of the presentations he gave at the 2026 Amputation Prevention Symposium on what is needed to successfully perform deep venous arterialization.
Zola N'Dandu, MD, discusses one of the presentations he gave at the 2026 Amputation Prevention Symposium on what is needed to successfully perform deep venous arterialization.
Zola N'Dandu, MD, discusses one...
10/07/2026
Vascular Disease Management
Fadi Saab MD
AMP 2026
Lessons Learned Throughout the Deep Venous Arterialization Evolution: Yesterday and Today
09/29/2026
Fadi Saab, MD, FACC, FSCAI
In this video, interventional cardiologist Fadi Saab, MD discusses one of the presentations he gave at AMP 2026.
In this video, interventional cardiologist Fadi Saab, MD discusses one of the presentations he gave at AMP 2026.
In this video, interventional...
09/29/2026
Vascular Disease Management
Jill Sommerset RVT
AMP 2026
Pre-op Mapping for Deep Vein Arterialization
09/28/2026
Jill Sommerset, RVT
Jill Sommerset, RVT, FSVU, discusses her AMP 2026 presentation on pre-op mapping for DVA.
Jill Sommerset, RVT, FSVU, discusses her AMP 2026 presentation on pre-op mapping for DVA.
Jill Sommerset, RVT, FSVU,...
09/28/2026
Vascular Disease Management
Dr Yana Etkin
AMP 2026
Failing Deep Vein Arterialization: Early Detection and Timely Reintervention Strategies
09/22/2026
Yana Etkin, MD, FSVS, FACS
Vascular surgeon Yana Etkin, MD, discusses her AMP 2026 presentation on failing deep vein arterialization. 
Vascular surgeon Yana Etkin, MD, discusses her AMP 2026 presentation on failing deep vein arterialization. 
Vascular surgeon Yana Etkin, MD,...
09/22/2026
Vascular Disease Management
Dr Salazar speaks at ISET 2026
ISET 2026
Venous Valve Technology: When Will It Be Standard of Care?
04/01/2026
Gloria Salazar, MD, FSIR
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current...
04/01/2026
Vascular Disease Management
Video
Venous Thromboembolism: A Cost Analysis
10/15/2025
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In this video, Clinical Editor Craig Walker, MD, comments on Mary Yost’s article, “The Cost of Venous Thromboembolism”.
In this video, Clinical Editor Craig Walker, MD, comments on Mary Yost’s article, “The Cost of Venous Thromboembolism”.
In this video, Clinical Editor...
10/15/2025
Vascular Disease Management
Dr Xhorlina Marko
ISET 2025
An Update on the Data and Devices for the Treatment of DVT
03/21/2025
Xhorlina Marko, MD
Iinterventional radiologist Xhorlina Marko, MD, from Henry Ford Health in Detroit, Michigan, discusses the details of her ISET 2025 presentation on the latest data and devices for DVT treatment.
Iinterventional radiologist Xhorlina Marko, MD, from Henry Ford Health in Detroit, Michigan, discusses the details of her ISET 2025 presentation on the latest data and devices for DVT treatment.
Iinterventional radiologist...
03/21/2025
Vascular Disease Management
Dr Osman Ahmed
ISET 2024
Management of Acute and Chronic Lower Extremity Venous Obstruction
03/05/2024

Osman Ahmed, MD
UChicago Medicine, Chicago, Illinois

Osman Ahmed, MD UChicago Medicine, Ch...
Watch as Dr. Osman Ahmed discusses his ISET 2024 presentation on acute and chronic lower extremity venous obstruction.
Watch as Dr. Osman Ahmed discusses his ISET 2024 presentation on acute and chronic lower extremity venous obstruction.
Watch as Dr. Osman Ahmed...
03/05/2024
Vascular Disease Management
Dr Daye
ISET 2024
Potential AI Applications for Intervention; AI for Venous Disease
02/09/2024
Dania Daye, MD, PhD
In this video, Dr. Dania Daye discusses her ISET 2024 presentations on the use of artificial intelligence in interventional specialties.
In this video, Dr. Dania Daye discusses her ISET 2024 presentations on the use of artificial intelligence in interventional specialties.
In this video, Dr. Dania Daye...
02/09/2024
Vascular Disease Management
Fortegra
Sponsored Video
GORE® VIABAHN® FORTEGRA Venous Stent
11/01/2026
Purpose-built for the treatment of IVC obstruction—with or without combined iliofemoral obstruction—the FORTEGRA Venous Stent is the first deep venous stent indicated specifically for this anatomy.
Purpose-built for the treatment of IVC obstruction—with or without combined iliofemoral obstruction—the FORTEGRA Venous Stent is the first deep venous stent indicated specifically for this anatomy.
Purpose-built for the treatment...
11/01/2026
Vascular Disease Management
Tim Wittig, MD
AMP 2026
Primary Outcomes of the MOTIV BTK Sirolimus-Eluting Bioresorbable Vascular Scaffold for the Treatment of Infrapopliteal Lesions
10/20/2026
Tim Wittig, MD
Dr Tim Wittig fdiscusses his presentation on the MOTIV BTK sirolimus-eluting bioresorbable vascular scaffold (REVA Medical).
Dr Tim Wittig fdiscusses his presentation on the MOTIV BTK sirolimus-eluting bioresorbable vascular scaffold (REVA Medical).
Dr Tim Wittig fdiscusses his...
10/20/2026
Vascular Disease Management
Zola N'Dandu, MD
AMP 2026
Unmet Needs in Deep Venous Arterialization Technology
10/07/2026
Zola N'Dandu, MD
Zola N'Dandu, MD, discusses one of the presentations he gave at the 2026 Amputation Prevention Symposium on what is needed to successfully perform deep venous arterialization.
Zola N'Dandu, MD, discusses one of the presentations he gave at the 2026 Amputation Prevention Symposium on what is needed to successfully perform deep venous arterialization.
Zola N'Dandu, MD, discusses one...
10/07/2026
Vascular Disease Management
Mike Watts, MD, FSIR
AMP 2026
Healing That Lasts: Real-World 90-Day Outcomes Demonstrating the Durability of Serration Remodeling Therapy
10/06/2026
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, discusses his AMP 2026 presentation on serration remodeling therapy.
Mike Watts, MD, FSIR, discusses his AMP 2026 presentation on serration remodeling therapy.
Mike Watts, MD, FSIR, discusses...
10/06/2026
Vascular Disease Management
Fadi Saab MD
AMP 2026
Lessons Learned Throughout the Deep Venous Arterialization Evolution: Yesterday and Today
09/29/2026
Fadi Saab, MD, FACC, FSCAI
In this video, interventional cardiologist Fadi Saab, MD discusses one of the presentations he gave at AMP 2026.
In this video, interventional cardiologist Fadi Saab, MD discusses one of the presentations he gave at AMP 2026.
In this video, interventional...
09/29/2026
Vascular Disease Management
Jill Sommerset RVT
AMP 2026
Pre-op Mapping for Deep Vein Arterialization
09/28/2026
Jill Sommerset, RVT
Jill Sommerset, RVT, FSVU, discusses her AMP 2026 presentation on pre-op mapping for DVA.
Jill Sommerset, RVT, FSVU, discusses her AMP 2026 presentation on pre-op mapping for DVA.
Jill Sommerset, RVT, FSVU,...
09/28/2026
Vascular Disease Management
Dr Yana Etkin
AMP 2026
Failing Deep Vein Arterialization: Early Detection and Timely Reintervention Strategies
09/22/2026
Yana Etkin, MD, FSVS, FACS
Vascular surgeon Yana Etkin, MD, discusses her AMP 2026 presentation on failing deep vein arterialization. 
Vascular surgeon Yana Etkin, MD, discusses her AMP 2026 presentation on failing deep vein arterialization. 
Vascular surgeon Yana Etkin, MD,...
09/22/2026
Vascular Disease Management
Dr Anahita Dua speaks at AMP 2026
AMP 2026
The Changing Face of Chronic Limb-Threatening Ischemia: Global Epidemiology and the Untold Data Story
09/10/2026
Anahita Dua, MD, MS, MBA, FACS
Dr Anahita Dua discusses the changing face of CLTI.
Dr Anahita Dua discusses the changing face of CLTI.
Dr Anahita Dua discusses the...
09/10/2026
Vascular Disease Management
Dr N'Dandu speaks at AMP 2026
AMP 2026
Woundosome for Wound Healing
09/01/2026
Zola N'Dandu, MD
Dr Zola N'Dandu discusses the woundosome concept and its impact on outcomes in patients with chronic limb-threatening ischemia.
Dr Zola N'Dandu discusses the woundosome concept and its impact on outcomes in patients with chronic limb-threatening ischemia.
Dr Zola N'Dandu discusses the...
09/01/2026
Vascular Disease Management
Marianne Brodmann, MD, speaks at AMP 2026.
AMP 2026
Long-Term Evidence From DEEPER OUS
08/25/2026
Marianne Brodmann, MD
Dr Marianne Brodmann discusses the latest results from the DEEPER OUS trial.
Dr Marianne Brodmann discusses the latest results from the DEEPER OUS trial.
Dr Marianne Brodmann discusses...
08/25/2026
Vascular Disease Management

Presentations

Mike Watts, MD, FSIR
AMP 2026
When Economics Meets Innovation: Matching Deep Venous Arterialization to the Right Site of Service
08/07/2026
Mike Watts, MD, FSIR
Dr Mike Watts examines an important question surrounding DVA: not simply whether the procedure can prevent amputation in patients with no-option CLTI, but how the economics of care delivery influence where and how it can be successfully...
Dr Mike Watts examines an important question surrounding DVA: not simply whether the procedure can prevent amputation in patients with no-option CLTI, but how the economics of care delivery influence where and how it can be successfully...
Dr Mike Watts examines an...
08/07/2026
Vascular Disease Management
Dr Yana Etkin
AMP 2026
Early Detection and Timely Reintervention Drive Success After Deep Venous Arterialization
08/07/2026
Yana Etkin, MD, FSVS, FACS
Yana Etkin, MD,  presented an in-depth review of strategies for identifying and managing failing DVA, emphasizing that long-term success depends not only on creating the DVA circuit but also on maintaining its patency through vigilant...
Yana Etkin, MD,  presented an in-depth review of strategies for identifying and managing failing DVA, emphasizing that long-term success depends not only on creating the DVA circuit but also on maintaining its patency through vigilant...
Yana Etkin, MD,  presented an...
08/07/2026
Vascular Disease Management
Dr Mike Watts
ISET 2026
How I Do It: Distal Deep Venous Arterialization in the OBL
02/11/2026
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from...
02/11/2026
Vascular Disease Management
Dr William Kuo
ISET 2026
Clot Management in the IVC: Matching the Device to the Disease
02/11/2026
William T. Kuo, MD
During a Wednesday afternoon session at ISET 2026, Sr William Kuo walked attendees through a practical, case-based approach to managing inferior vena cava thrombosis.
During a Wednesday afternoon session at ISET 2026, Sr William Kuo walked attendees through a practical, case-based approach to managing inferior vena cava thrombosis.
During a Wednesday afternoon...
02/11/2026
Vascular Disease Management
Alexander Misono, MD, MBA, RPVI
ISET 2026
Lower Extremity Venous Duplex Imaging: Why the Details Matter More Than Ever
02/09/2026
Alexander Misono, MD, MBA, RPVI
Alexander Misono, MD, MBA, RPVI, challenged attendees to rethink how lower extremity venous duplex imaging fits into the modern DVT care pathway.
Alexander Misono, MD, MBA, RPVI, challenged attendees to rethink how lower extremity venous duplex imaging fits into the modern DVT care pathway.
Alexander Misono, MD, MBA, RPVI,...
02/09/2026
Vascular Disease Management
Cees Wittens, MD
LINC 2026
A New Modular Approach to Venous Stenting With ALTA's Multi-Segmented, Tapered Design
01/26/2026
Cees Wittens, MD
Cees Wittens, Emeritus Professor of Venous Surgery at Maastricht University Medical Center (UMC+, the Netherlands) and the European College of Phlebology (ECoP) shares information about the Venous Stent ALTA®.
Cees Wittens, Emeritus Professor of Venous Surgery at Maastricht University Medical Center (UMC+, the Netherlands) and the European College of Phlebology (ECoP) shares information about the Venous Stent ALTA®.
Cees Wittens, Emeritus Professor...
01/26/2026
Vascular Disease Management
Gerard O'Sullivan, MD
LINC 2026
Tips and Tricks in IVC Reconstruction
01/26/2026
Gerard J. O'Sullivan, MD
Gerard O’Sullivan, MD, elaborates on approaches shaped by common pitfalls in IVC reconstruction and their prevention.
Gerard O’Sullivan, MD, elaborates on approaches shaped by common pitfalls in IVC reconstruction and their prevention.
Gerard O’Sullivan, MD,...
01/26/2026
Vascular Disease Management
Dr Harnain
ISET 2025
Case Studies & Discussion: Venous Compression Syndromes
02/02/2025
Read about Dr Christopher M. Harnain's ISET 2025 presentation on venous compression syndromes.
Read about Dr Christopher M. Harnain's ISET 2025 presentation on venous compression syndromes.
Read about Dr Christopher M....
02/02/2025
Vascular Disease Management
Dr Jaffer
LINC 2025
Creating EndoAVF: New Evidence and Upcoming Trials
01/30/2025
Ounali Jaffer, MD, walked through his experience in using endoAVF and touched on the past, present, and future insights that may potentially drive this field. 
Ounali Jaffer, MD, walked through his experience in using endoAVF and touched on the past, present, and future insights that may potentially drive this field. 
Ounali Jaffer, MD, walked...
01/30/2025
Vascular Disease Management
Dr Hirsch
LINC 2025
Odds and Limitations of Duplex Sonography in the Diagnosis of PeVD
01/28/2025
Tobias Hirsch, MD
Dr Tobias Hirsch discusses his LINC 2025 presentation on diagnosing pelvic venous disorders with duplex sonography.
Dr Tobias Hirsch discusses his LINC 2025 presentation on diagnosing pelvic venous disorders with duplex sonography.
Dr Tobias Hirsch discusses his...
01/28/2025
Vascular Disease Management
Mike Watts, MD, FSIR
AMP 2026
When Economics Meets Innovation: Matching Deep Venous Arterialization to the Right Site of Service
08/07/2026
Mike Watts, MD, FSIR
Dr Mike Watts examines an important question surrounding DVA: not simply whether the procedure can prevent amputation in patients with no-option CLTI, but how the economics of care delivery influence where and how it can be successfully...
Dr Mike Watts examines an important question surrounding DVA: not simply whether the procedure can prevent amputation in patients with no-option CLTI, but how the economics of care delivery influence where and how it can be successfully...
Dr Mike Watts examines an...
08/07/2026
Vascular Disease Management
Dr Yana Etkin
AMP 2026
Early Detection and Timely Reintervention Drive Success After Deep Venous Arterialization
08/07/2026
Yana Etkin, MD, FSVS, FACS
Yana Etkin, MD,  presented an in-depth review of strategies for identifying and managing failing DVA, emphasizing that long-term success depends not only on creating the DVA circuit but also on maintaining its patency through vigilant...
Yana Etkin, MD,  presented an in-depth review of strategies for identifying and managing failing DVA, emphasizing that long-term success depends not only on creating the DVA circuit but also on maintaining its patency through vigilant...
Yana Etkin, MD,  presented an...
08/07/2026
Vascular Disease Management
Alik Farber, MD
AMP 2026
Four-Year BEST-CLI Data Reinforce a Team-Based Future for Limb Salvage
08/07/2026
Alik Farber, MD
Alik Farber, MD, MBA, presented the latest 4-year findings from the landmark BEST-CLI trial. He challenged attendees to move beyond the long-standing debate of surgery vs endovascular intervention and instead embrace an evidence-based,...
Alik Farber, MD, MBA, presented the latest 4-year findings from the landmark BEST-CLI trial. He challenged attendees to move beyond the long-standing debate of surgery vs endovascular intervention and instead embrace an evidence-based,...
Alik Farber, MD, MBA, presented...
08/07/2026
Vascular Disease Management
Dr Eric Secemsky
AMP 2026
Defining Optimal Medical Therapy for CLTI in 2026
08/07/2026
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
Dr Eric Secemsky presented a review of the evidence supporting contemporary medical management for patients with PAD and CLTI, emphasizing that pharmacologic therapy remains an essential pillar of reducing cardiovascular events.
Dr Eric Secemsky presented a review of the evidence supporting contemporary medical management for patients with PAD and CLTI, emphasizing that pharmacologic therapy remains an essential pillar of reducing cardiovascular events.
Dr Eric Secemsky presented a...
08/07/2026
Vascular Disease Management
Dr Ralf Langhoff
AMP 2026
Retrograde Access Moves to the Forefront: Rethinking CTO Crossing Strategies
08/06/2026
Ralf Langhoff, MD
During a Thursday afternoon session at the Amputation Prevention Symposium 2026, Ralf Langhoff, MD, asked attendees to reconsider when retrograde access should be used for chronic total occlusion (CTO) interventions.
During a Thursday afternoon session at the Amputation Prevention Symposium 2026, Ralf Langhoff, MD, asked attendees to reconsider when retrograde access should be used for chronic total occlusion (CTO) interventions.
During a Thursday afternoon...
08/06/2026
Vascular Disease Management
Dr Ramon Varcoe
AMP 2026
Bioresorbable Below-the-Knee Technology Shows Durable Promise for CLTI
08/06/2026
Ramon L. Varcoe, MBBS, MS, PhD
Dr Ramon L. Varcoe presented an update on bioresorbable BTK technology, highlighting the growing body of evidence supporting the Esprit™ BTK drug-eluting resorbable scaffold (Abbott Cardiovascular) for the treatment of CLTI.
Dr Ramon L. Varcoe presented an update on bioresorbable BTK technology, highlighting the growing body of evidence supporting the Esprit™ BTK drug-eluting resorbable scaffold (Abbott Cardiovascular) for the treatment of CLTI.
Dr Ramon L. Varcoe presented an...
08/06/2026
Vascular Disease Management
Dr Pradeep Nair
AMP 2026
A New Approach to Crossing and Preparing Complex Peripheral Chronic Total Occlusions
08/06/2026
Pradeep K. Nair, MD, FACC, FSCAI
Dr Pradeep K. Nair presented the clinical rationale, engineering design, pivotal clinical data, and early real-world experience with the Santreva-ATK Endovascular Revascularization Catheter (AngioSafe).
Dr Pradeep K. Nair presented the clinical rationale, engineering design, pivotal clinical data, and early real-world experience with the Santreva-ATK Endovascular Revascularization Catheter (AngioSafe).
Dr Pradeep K. Nair presented the...
08/06/2026
Vascular Disease Management
S Jay Mathews, MD
AMP 2026
SELUTION SLR Highlights the Growing Role of Sirolimus Drug-Eluting Balloons in CLTI
08/06/2026
S. Jay Mathews, MD, MS, FACC, FSCAI
This presentation examined the evolving evidence supporting the SELUTION SLR sirolimus drug-eluting balloon (Cordis) as a treatment strategy for femoropopliteal and BTK PAD, with particular emphasis on complex CLTI.
This presentation examined the evolving evidence supporting the SELUTION SLR sirolimus drug-eluting balloon (Cordis) as a treatment strategy for femoropopliteal and BTK PAD, with particular emphasis on complex CLTI.
This presentation examined the...
08/06/2026
Vascular Disease Management
Tim Wittig, MD
AMP 2026
MOTIV BTK Trial Demonstrates Promising Early Outcomes for Sirolimus-Eluting Bioresorbable Scaffold in CLTI
08/05/2026
Tim Wittig, MD
Tim Wittig, MD, presents the primary outcomes from the MOTIV BTK Trial, which evaluated the safety and efficacy of the sirolimus-eluting bioresorbable scaffold MOTIV BTK.
Tim Wittig, MD, presents the primary outcomes from the MOTIV BTK Trial, which evaluated the safety and efficacy of the sirolimus-eluting bioresorbable scaffold MOTIV BTK.
Tim Wittig, MD, presents the...
08/05/2026
Vascular Disease Management
Dr Eric Scott
AMP 2026
Using Imaging to Choose Between Endovascular Therapy and Surgical Bypass
08/05/2026
Eric C. Scott, MD
Dr Eric Scott presents presents a case-based discussion on how advanced vascular imaging should guide the decision between an endovascular-first or surgical bypass-first approach for patients with PAD and CLTI.
Dr Eric Scott presents presents a case-based discussion on how advanced vascular imaging should guide the decision between an endovascular-first or surgical bypass-first approach for patients with PAD and CLTI.
Dr Eric Scott presents presents...
08/05/2026
Vascular Disease Management

About Us

Vascular Disease Management™ (VDM), the official media partner of the International Symposium on Endovascular Therapy (ISET) and the Amputation Prevention Symposium (AMP), educates readers on the latest advancements in endovascular treatment strategies. 

Learn more about ISET and AMP and register for the events here:

ISET logo

AMP logo

Subscribe Now!

Vascular Disease Management Newsletter

News

Chronic Venous Disease
InVera Medical Reports 12-Month Results From Pilot Trial of InVera Infusion Device Showing Vein Closure in 90% of Patients, Statistically Significant Quality of Life Improvements, and Excellent Safety
04/21/2026
Novel Non-Thermal Procedure for Chronic Venous Disease Designed to Effectively Eliminate Need for Painful Injections Required for Thermal Ablation
Novel Non-Thermal Procedure for Chronic Venous Disease Designed to Effectively Eliminate Need for Painful Injections Required for Thermal Ablation
Novel Non-Thermal Procedure for...
04/21/2026
Vascular Disease Management
Post-Thrombotic Syndrome
Pivotal Study of Minimally Invasive Stent Therapy Shows Improved Quality of Life for Patients With Blood Clots
04/12/2026
NIH-sponsored C-TRACT Trial finds opportunity to treat often ignored DVT complication. TORONTO (April 13, 2026)—The results of a prominent, National Institutes of Health (NIH) sponsored study into the treatment of post-thrombotic syndrome...
NIH-sponsored C-TRACT Trial finds opportunity to treat often ignored DVT complication. TORONTO (April 13, 2026)—The results of a prominent, National Institutes of Health (NIH) sponsored study into the treatment of post-thrombotic syndrome...
NIH-sponsored C-TRACT Trial...
04/12/2026
Vascular Disease Management
Deep Venous Disease
Gore Gains FDA Approval for First Deep Venous Stent Indicated for the IVC and Iliofemoral Veins
01/06/2026
The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients. FLAGSTAFF, Ariz. (January 6, 2026) — W. L. Gore & Associates’...
The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients. FLAGSTAFF, Ariz. (January 6, 2026) — W. L. Gore & Associates’...
The GORE® VIABAHN® FORTEGRA...
01/06/2026
Vascular Disease Management
Venous Leg Ulcers
Spectrum Venous Leg Ulcer Study Demonstrates Clinical Support for Use of VenaSeal™ in Advanced Superficial Venous Disease
04/24/2025
Results from study indicate strong healing rate of chronic venous ulcers when VenaSeal™ is used in patients with advanced superficial venous disease Medtronic, the global leader in health care technology, today announced the primary and...
Results from study indicate strong healing rate of chronic venous ulcers when VenaSeal™ is used in patients with advanced superficial venous disease Medtronic, the global leader in health care technology, today announced the primary and...
Results from study indicate...
04/24/2025
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
The US FDA has approved its IDE application to initiate the QUADRA-PE study (NCT06672510) evaluating the Katana™ Thrombectomy System in patients with acute PE.
The US FDA has approved its IDE application to initiate the QUADRA-PE study (NCT06672510) evaluating the Katana™ Thrombectomy System in patients with acute PE.
The US FDA has approved its IDE...
11/04/2024
Vascular Disease Management
Zilver Vena Stent
Zilver Vena Stent Shows High Patency Across All Patient Groups in Three-Year Clinical Study
10/29/2024
Bloomington, Ind. — Cook Medical’s Zilver Vena® Venous Self-Expanding Stent has shown high rates of patency sustained for three years, according to recently published data in the Journal of Vascular and Interventional Radiology (JVIR).1 The...
Bloomington, Ind. — Cook Medical’s Zilver Vena® Venous Self-Expanding Stent has shown high rates of patency sustained for three years, according to recently published data in the Journal of Vascular and Interventional Radiology (JVIR).1 The...
Bloomington, Ind. — Cook...
10/29/2024
Vascular Disease Management
Venous Disease
New Randomized Controlled Data From Venaseal Spectrum Program Reinforces Evidence That Venaseal™ Closure System Is Safe and Effective
04/24/2024

Medtronic News Alert

Medtronic News Alert
Medtronic, the global leader in healthcare technology, today announced the VenaSeal Spectrum Program primary endpoints and 30-day modified Aberdeen Varicose Vein Questionnaire (AVVQ) results on the use of the VenaSeal™ closure system compared...
Medtronic, the global leader in healthcare technology, today announced the VenaSeal Spectrum Program primary endpoints and 30-day modified Aberdeen Varicose Vein Questionnaire (AVVQ) results on the use of the VenaSeal™ closure system compared...
Medtronic, the global leader in...
04/24/2024
Vascular Disease Management
News
Clarius and ThinkSono Introduce a New AI-Guided Ultrasound System Enabling Rapid Assessments of DVTs
04/05/2024

Clarius Mobile Health News

Clarius Mobile Health News
Having achieved CE Mark for sales in Europe and the UK, ThinkSono is now collaborating with Clarius on clinical studies in the United States to prepare for FDA submission VANCOUVER, BC, April 5, 2024 /PRNewswire/ -- Clarius Mobile Health,...
Having achieved CE Mark for sales in Europe and the UK, ThinkSono is now collaborating with Clarius on clinical studies in the United States to prepare for FDA submission VANCOUVER, BC, April 5, 2024 /PRNewswire/ -- Clarius Mobile Health,...
Having achieved CE Mark for...
04/05/2024
Vascular Disease Management
LAA Occluders
Late-Breaking One-Year Data Show Abbott's Next-Generation Amulet 360™ Device Continues to Demonstrate High Rates of Left Atrial Appendage Closure and Low Incidence of Stroke
11/03/2026
Late-breaking one-year VERITAS study results were presented at the Transcatheter Cardiovascular Therapeutics conference and simultaneously published in JACC: Cardiovascular Interventions;data show the device achieved high closure rates of...
Late-breaking one-year VERITAS study results were presented at the Transcatheter Cardiovascular Therapeutics conference and simultaneously published in JACC: Cardiovascular Interventions;data show the device achieved high closure rates of...
Late-breaking one-year...
11/03/2026
Vascular Disease Management
Intravascular Lithotripsy
Abbott's TECTONIC Clinical Trial Demonstrates Strong 30-day Outcomes and High Procedural Success for Its Investigational SonicForce™ Coronary Intravascular Lithotripsy System
11/03/2026
11/03/2026
Vascular Disease Management
Stroke Clinical Trials
Could A Drug for Leg Cramps Prevent a Second, Deadlier Stroke? 
10/30/2026
The trial is funded by the National Institute of Neurological Disorders and Stroke (NINDS) and is open to patients diagnosed within the last six months with an ischemic stroke or high-risk transient ischemic attack (TIA).
The trial is funded by the National Institute of Neurological Disorders and Stroke (NINDS) and is open to patients diagnosed within the last six months with an ischemic stroke or high-risk transient ischemic attack (TIA).
The trial is funded by the...
10/30/2026
Cath Lab Digest
Radiation Safety
Rampart Launches Vanguard™ at TCT 2026, Extending Total-Body Radiation Protection to Interventional Imagers
10/29/2026
Purpose-built head-of-table solution advances the Shed the Lead® movement as new multisociety guidance calls for enhanced radiation protection.
Purpose-built head-of-table solution advances the Shed the Lead® movement as new multisociety guidance calls for enhanced radiation protection.
Purpose-built head-of-table...
10/29/2026
Vascular Disease Management
Peripheral Arterial Bleeds
Instylla's Embrace® Hydrogel Embolic System Receives FDA Approval for Peripheral Arterial Bleeds
10/29/2026
10/29/2026
Vascular Disease Management
Large-Bore Closure
Haemonetics Announces FDA Approval of PerQseal Elite Vascular Closure System
10/27/2026
The PerQseal Elite system provides sutureless, large-bore vascular closure following structural heart and endovascular procedures performed with 14 – 22F sheaths. Its fully bioabsorbable patch seals arteriotomies up to 26F from within the...
The PerQseal Elite system provides sutureless, large-bore vascular closure following structural heart and endovascular procedures performed with 14 – 22F sheaths. Its fully bioabsorbable patch seals arteriotomies up to 26F from within the...
The PerQseal Elite system...
10/27/2026
Cath Lab Digest
FDA Approvals
Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
10/20/2026
ALAMEDA, Calif. -- Penumbra, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the treatment of deep vein thrombosis (DVT) to the company's Lightning™ computer assisted vacuum thrombectomy (CAVT™)...
ALAMEDA, Calif. -- Penumbra, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the treatment of deep vein thrombosis (DVT) to the company's Lightning™ computer assisted vacuum thrombectomy (CAVT™)...
ALAMEDA, Calif. -- Penumbra,...
10/20/2026
Cath Lab Digest
Vertex PE System (Jupiter Endovascular)
Pulmonary Embolism
Jupiter Endovascular Announces Publication of SPIRARE II Pivotal Trial Results Showing Vertex Thrombectomy System Normalized Hemodynamics in 50% of Pulmonary Embolism Patients
10/19/2026
The Vertex system leverages the company’s proprietary Transforming Fixation (TFX) platform technology, a single catheter designed to navigate flexibly through the right heart and stabilize on-demand in the pulmonary arteries for precise,...
The Vertex system leverages the company’s proprietary Transforming Fixation (TFX) platform technology, a single catheter designed to navigate flexibly through the right heart and stabilize on-demand in the pulmonary arteries for precise,...
The Vertex system leverages the...
10/19/2026
Cath Lab Digest
Endovascular Aortic Repair
FDA Approves GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis for Expanded use in FEVAR and BEVAR
10/15/2026
10/15/2026
Vascular Disease Management
Deep Learning
Deep Learning Model Predicts Hepatocellular Carcinoma Progression Following Transarterial Chemoembolization
10/09/2026
Laura Simson, MA
A prediction model combining deep learning, radiomics, and clinical data demonstrated promising performance in predicting disease progression following transarterial chemoembolization in patients with hepatocellular carcinoma.
A prediction model combining deep learning, radiomics, and clinical data demonstrated promising performance in predicting disease progression following transarterial chemoembolization in patients with hepatocellular carcinoma.
A prediction model combining...
10/09/2026
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use